52
Baylor Scott & White Heart and Vascular Hospital – Fort Worth Structural Heart Disease Program
Valve Disorders Center
A part of the comprehensive Structural Heart Disease Program , the Valve Disorders Center at Baylor Scott & White Heart and Vascular Hospital - Fort Worth reached more than 200 TAVRs in June 2020 — the total since its beginning in late October 2017 . With referrals coming from all over Tarrant County and the western region of Texas , the Valve Disorders Center is comprised of a multidisciplinary team of clinicians , including cardiologists , interventional cardiologists , cardiothoracic surgeons , imaging specialists and cardiac care nurses . The multidisciplinary team meets to review each potential patient ’ s case and determine the most appropriate approach to valve repair or replacement .
Therapies available include :
• Transcatheter aortic valve replacement ( TAVR )
• Transcatheter mitral valve repair ( TMVR ), especially for high surgical risk patients with severe mitral regurgitation
• Minimally invasive aortic , mitral , pulmonic and tricuspid valve repair and replacement using sternal sparing , port-access approaches
• Transcatheter valve-in-valve implantation for failed bioprosthetic valves in the aortic and mitral valves
The Valve Disorders Center is supported by a team of coordinators and data analysts who continually review and report outcomes . Valve Disorders Center medical staff members in fiscal year 2020 included :
Interventional cardiologists :
• Farhan Ali , MD , MA , MPH , FACC , FSCAI , RPVI
• Sukesh Burjonroppa , MD , FACC , FSCAI
• Vijay Kalaria , MD , FACC , FSCAI
• Abdul Keylani , MD
• Amir Malik , MD , FACC , FSCAI
Cardiothoracic surgeons :
• Gonzalo V . Gonzalez-Stawinski , MD
• Reza Khalafi , MD , FACS , FCCP
• Anita Krueger , MD
• Jeffrey Wu , MD
Mitral valve program
Collaborating with the cardiothoracic surgeons on the medical staff of Baylor Scott & White – Fort Worth , the mitral valve program ’ s specialists treat both degenerative mitral valve disease as well as functional mitral valve conditions . Other patients may present with :
• Degenerative disease or congenital anomalies
• Ischemic cardiomyopathy
• Acute endocarditis
• Carcinoid heart disease
• Mitral annular calcifications
Treatment options :
• Medical management
• Percutaneous balloon valvuloplasty
• Percutaneous mitral balloon commissurotomy or surgical commissurotomy
• Valvulotomy
• Transcatheter procedures
• Minimally invasive procedures
• Surgical repair or replacement
Although mitral valve repair is more surgically complex than replacement , it reduces the need for blood thinners and complications of prosthetic valves . Research indicates early mitral valve repair leads to better outcomes for symptoms , such as ventricular dysfunction or dilation , pulmonary hypertension and atrial fibrillation . In addition , mitral valve repair provides better long-term patient survival , better preservation of heart function , lower risk of complications , and usually eliminates the need for long-term use of blood thinners ( anticoagulants ).+
+ Nishimura RA , Otto CM , Benow RO , et al . 2014 AHA / ACC guidelines for management of patient with valvular heart disease : a report of the American College of Cardiology / American Heart Association Task Force on Practice Guidelines . Circulation . 2014 .